Page last updated: 2024-09-03

n-acetyllactosamine and Pleural Effusion, Malignant

n-acetyllactosamine has been researched along with Pleural Effusion, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrasco, J; Courtoy, PJ; Demotte, N; Lurquin, C; Moser, M; Schmidt, C; Squifflet, JL; Thielemans, K; van der Bruggen, P; Van Der Smissen, P; Weynand, B; Wieërs, G	1

Other Studies

1 other study(ies) available for n-acetyllactosamine and Pleural Effusion, Malignant

Article	Year
A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice. Cancer research, 2010, Oct-01, Volume: 70, Issue:19 Topics: Amino Sugars; Animals; Ascites; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Galectin 3; Humans; Interferon-gamma; Ligands; Lymphocytes, Tumor-Infiltrating; Mastocytoma; Melanoma; Mice; Neoplasms; Pleural Effusion, Malignant; Polysaccharides; Receptors, Antigen, T-Cell	2010

Article

Year

A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.

Cancer research, 2010, Oct-01, Volume: 70, Issue:19

Topics: Amino Sugars; Animals; Ascites; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Galectin 3; Humans; Interferon-gamma; Ligands; Lymphocytes, Tumor-Infiltrating; Mastocytoma; Melanoma; Mice; Neoplasms; Pleural Effusion, Malignant; Polysaccharides; Receptors, Antigen, T-Cell

2010